Page last updated: 2024-08-26

bosentan anhydrous and Arteriovenous Malformations

bosentan anhydrous has been researched along with Arteriovenous Malformations in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Morrell, NW; Pepke-Zaba, J; Sheares, K; Soon, E; Southwood, M	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Arteriovenous Malformations

Article	Year
Better off blue: BMPR-2 mutation, arteriovenous malformation, and pulmonary arterial hypertension. American journal of respiratory and critical care medicine, 2014, Jun-01, Volume: 189, Issue:11 Topics: Antihypertensive Agents; Arteriovenous Malformations; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Disease Progression; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Middle Aged; Mutation; Pedigree; Piperazines; Pulmonary Artery; Pulmonary Veins; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents	2014

Article

Year

Better off blue: BMPR-2 mutation, arteriovenous malformation, and pulmonary arterial hypertension.

American journal of respiratory and critical care medicine, 2014, Jun-01, Volume: 189, Issue:11

Topics: Antihypertensive Agents; Arteriovenous Malformations; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Disease Progression; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Middle Aged; Mutation; Pedigree; Piperazines; Pulmonary Artery; Pulmonary Veins; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents

2014